Sclerosis multiplex (SM): nyitott vizsgálatok itt: Kína

• NCT07225504

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Kísérleti kezelés · 3. fázis · Novartis Pharmaceuticals

  Beijing · Changchun · Chongqing · Guangzhou · Hangzhou · Hohhot · Shanghai · Shenyang · Suzhou · Taiyuan · Tianjin · Wenzhou · Wuhan · Xianyang · Yinchuan · Zhengzhou · Zunyi

  Regiszter frissítve: 2026-10-13

• NCT07325292

  Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  Kísérleti kezelés · 3. fázis · Sanofi

  Beijing · Chengdu · Chengdu · Dongguan · Guangzhou · Jiazhuang · Shenyang

  Regiszter frissítve: 2026-10-13

• NCT07827716

  A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple Sclerosis

  Kísérleti kezelés · 2. fázis · Chuan Qin

  Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

  Regiszter frissítve: 2026-09-18

• NCT07748637

  A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis

  Kísérleti kezelés · Korai 1. fázis · Daishi Tian

  Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

  Regiszter frissítve: 2026-09-14

• NCT07776743

  A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis

  Kísérleti kezelés · 2. fázis · Guangzhou Lupeng Pharmaceutical Company LTD.

  Beijing Tiantan Hospital,Capital Medical University, Beijing

  Regiszter frissítve: 2026-08-20

• NCT07756268

  Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis

  Kísérleti kezelés · 1/2. fázis · Tongji Hospital

  Tongji Hospital Tongji Medical College of Hust, Wuhan

  Regiszter frissítve: 2026-08-10

• NCT07587125

  Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis

  Kísérleti kezelés · 1. fázis · Xijing Hospital

  Xijing hospital, Xi'an

  Regiszter frissítve: 2026-08-05

• NCT06502015

  Biomarkers in Autoimmune Disease of Nervous System

  Kutatás · Tongji Hospital

  Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

  Regiszter frissítve: 2026-07-29

• NCT07676266

  A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

  Kísérleti kezelés · 1. fázis · The Affiliated Hospital of Qingdao University

  The Affiliated Hospital of Qingdao University, Qingdao

  Regiszter frissítve: 2026-06-30

• NCT07653984

  Cohort Study on Neuroimmune Diseases in the Reproductive Age

  Kutatás · Third Affiliated Hospital, Sun Yat-Sen University

  The Third Affiliated Hospital,Sun Yat-Sen University, Guangzhou

  Regiszter frissítve: 2026-06-17

• NCT04106830

  Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

  Kutatás · Beijing Tiantan Hospital

  Beijing Tiantan Hospital, Beijing

  Regiszter frissítve: 2026-06-15

• NCT07303790

  This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis

  Kísérleti kezelés · Korai 1. fázis · Daishi Tian

  Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Hubei

  Regiszter frissítve: 2026-05-22

• NCT07593911

  A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases

  Kísérleti kezelés · Beijing GoBroad Hospital

  Beijing GoBroad Hospital, Beijing

  Regiszter frissítve: 2026-05-18

• NCT07337785

  CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

  Kísérleti kezelés · Korai 1. fázis · Tongji Hospital

  Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

  Regiszter frissítve: 2026-05-12

• NCT07526493

  Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

  Kísérleti kezelés · 1. fázis · Tongji Hospital

  Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

  Regiszter frissítve: 2026-05-12

• NCT07523100

  A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.

  Kísérleti kezelés · 1. fázis · Daishi Tian

  Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan

  Regiszter frissítve: 2026-04-13

• NCT07392528

  Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

  Kísérleti kezelés · Korai 1. fázis · Tianjin Huanhu Hospital

  Tianjin Huanhu Hospital, Tianjin

  Regiszter frissítve: 2026-02-11

• NCT07333196

  Tongji NADs Cohort

  Kutatás · Tongji Hospital

  Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

  Regiszter frissítve: 2026-01-21

• NCT07353216

  Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels

  Kutatás · Third Affiliated Hospital, Sun Yat-Sen University

  The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou

  Regiszter frissítve: 2026-01-20

• NCT06643858

  Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)

  Kutatás · Beijing Tiantan Hospital

  Beijing Tiantan Hospital,Capital Medical University, Beijing

  Regiszter frissítve: 2025-12-30

• NCT06939166

  Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

  Kísérleti kezelés · Korai 1. fázis · Tianjin Huanhu Hospital

  Tianjin Huanhu Hospital, Tianjin

  Regiszter frissítve: 2025-12-15

• NCT07087873

  Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases

  Kísérleti kezelés · Xuanwu Hospital, Beijing

  Xuanwu Hospital, Capital Medical University, Beijing

  Regiszter frissítve: 2025-07-28

• NCT06249438

  A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

  Kísérleti kezelés · 1. fázis · RenJi Hospital

  Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai

  Regiszter frissítve: 2025-07-25

• NCT06968039

  Effectiveness of Personalized Alternating Current Stimulation for Treating Cognitive Impairment in CNS Demyelination Patients

  Kísérleti kezelés · Xuanwu Hospital, Beijing

  Xuanwu Hospital, Capital Medical University, Beijing

  Regiszter frissítve: 2025-05-13

• NCT06485232

  Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

  Kísérleti kezelés · Korai 1. fázis · Xuanwu Hospital, Beijing

  Xuanwu Hospital, Capital Medical University, Beijing

  Regiszter frissítve: 2025-01-01

Minden vizsgálat (Sclerosis multiplex (SM)) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek